Resveratrol promotes Rac activity in breast cancer cells by expressing dominant-negative Cdc42 or Rac and preserving filopodia responsiveness, so Rac and Cdc42 may regulate actin cytoskeleton signaling differently at low and high concentrations. The gene discussed is CDC42; the disease is breast cancer.